Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
about
MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic SclerosisUpdate on biomarkers in systemic sclerosis: tools for diagnosis and treatmentToll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developmentsPathophysiology of systemic sclerosisMultifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.Update on macrophages and innate immunity in sclerodermaKeloids: Animal models and pathologic equivalents to study tissue fibrosis.B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis.Fibrogenesis, novel lessons from animal models.Role of innate immune system in systemic sclerosis.Recent advances in animal models of systemic sclerosis.Innate Immunity in Systemic Sclerosis.Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice.Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.Toll-like receptor 4 gene polymorphism downregulates gene expression and involves in susceptibility to bladder cancer.Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma.Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
P2860
Q26781257-8BDE0B4E-420E-44DE-BF09-A35369CB7759Q26995542-A6A70635-F60D-4117-8F76-2A87B2355B53Q28067211-380351AF-9361-4A8A-8331-7CB097897CD1Q28072568-F9743469-3370-4540-AB2A-AB3FF3328551Q36371453-8E257B1D-85B7-4A93-BDFC-90A54A48E63EQ36607887-76FA290E-4E79-49D2-AE69-91792654D8E1Q36828407-BCD12D48-4E46-456D-9D15-DEF1E934F2DBQ37627201-8D909380-E738-4676-918D-30E97B8AB434Q38542592-81EB8A69-EF2D-452E-A86D-C5369936DC9AQ38544560-6AEC06AA-D4D0-446D-8AD3-94817300C33AQ38701983-BF8A2E36-5A7B-4D18-A29D-5E8BE624C13FQ39100157-BDADAAE4-B834-475E-B71D-A4495A0D74DCQ39393743-9F3B7E49-565D-49BC-BE57-22787E4B9811Q40321155-49E886C1-4075-4A89-A103-6EBEAE847948Q40368781-51981DEC-C6D1-4CB8-8C6A-B4B1B99C095EQ41729923-3FEE22F6-28EA-4EEC-A5E0-FE2C8910A668Q46835566-C2C253B4-9238-4206-96C8-7F36666EAD91Q47095125-8923AB36-FDC4-4A47-896A-74F485FBCC43Q47753846-A9B16EBF-4950-4D59-954A-3FAC833DBFC8Q57175037-5543BC96-7A3D-4870-9184-C549F2DC9DEA
P2860
Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Amelioration of tissue fibrosi ...... models of systemic sclerosis.
@en
Amelioration of tissue fibrosi ...... models of systemic sclerosis.
@nl
type
label
Amelioration of tissue fibrosi ...... models of systemic sclerosis.
@en
Amelioration of tissue fibrosi ...... models of systemic sclerosis.
@nl
prefLabel
Amelioration of tissue fibrosi ...... models of systemic sclerosis.
@en
Amelioration of tissue fibrosi ...... models of systemic sclerosis.
@nl
P2093
P2860
P356
P1476
Amelioration of tissue fibrosi ...... models of systemic sclerosis.
@en
P2093
Kaname Akamata
Makoto Sugaya
Shinichi Sato
Shinji Noda
Takafumi Kadono
Takashi Taniguchi
Takehiro Takahashi
Tetsuo Toyama
Yayoi Tada
Yohei Ichimura
P2860
P304
P356
10.1002/ART.38901
P577
2015-01-01T00:00:00Z